BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25080445)

  • 1. Selective inhibition of regulatory T cells by targeting the PI3K-Akt pathway.
    Abu-Eid R; Samara RN; Ozbun L; Abdalla MY; Berzofsky JA; Friedman KM; Mkrtichyan M; Khleif SN
    Cancer Immunol Res; 2014 Nov; 2(11):1080-9. PubMed ID: 25080445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential PI3Kδ Signaling in CD4
    Ahmad S; Abu-Eid R; Shrimali R; Webb M; Verma V; Doroodchi A; Berrong Z; Samara R; Rodriguez PC; Mkrtichyan M; Khleif SN
    Cancer Res; 2017 Apr; 77(8):1892-1904. PubMed ID: 28108509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-126 regulates the induction and function of CD4(+) Foxp3(+) regulatory T cells through PI3K/AKT pathway.
    Qin A; Wen Z; Zhou Y; Li Y; Li Y; Luo J; Ren T; Xu L
    J Cell Mol Med; 2013 Feb; 17(2):252-64. PubMed ID: 23301798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hPMSC transplantation restoring ovarian function in premature ovarian failure mice is associated with change of Th17/Tc17 and Th17/Treg cell ratios through the PI3K/Akt signal pathway.
    Yin N; Wang Y; Lu X; Liu R; Zhang L; Zhao W; Yuan W; Luo Q; Wu H; Luan X; Zhang H
    Stem Cell Res Ther; 2018 Feb; 9(1):37. PubMed ID: 29444704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAFF promotes T cell activation through the BAFF-BAFF-R-PI3K-Akt signaling pathway.
    Hu S; Wang R; Zhang M; Liu K; Tao J; Tai Y; Zhou W; Wang Q; Wei W
    Biomed Pharmacother; 2019 Jun; 114():108796. PubMed ID: 30921706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-2-deprivation and TGF-beta are two non-redundant suppressor mechanisms of CD4+CD25+ regulatory T cell which jointly restrain CD4+CD25- cell activation.
    Wang G; Khattar M; Guo Z; Miyahara Y; Linkes SP; Sun Z; He X; Stepkowski SM; Chen W
    Immunol Lett; 2010 Aug; 132(1-2):61-8. PubMed ID: 20570629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transiently reduced PI3K/Akt activity drives the development of regulatory function in antigen-stimulated Naïve T-cells.
    Etemire E; Krull M; Hasenberg M; Reichardt P; Gunzer M
    PLoS One; 2013; 8(7):e68378. PubMed ID: 23874604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSP70 enhances immunosuppressive function of CD4(+)CD25(+)FoxP3(+) T regulatory cells and cytotoxicity in CD4(+)CD25(-) T cells.
    Wachstein J; Tischer S; Figueiredo C; Limbourg A; Falk C; Immenschuh S; Blasczyk R; Eiz-Vesper B
    PLoS One; 2012; 7(12):e51747. PubMed ID: 23300563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells.
    Zeiser R; Leveson-Gower DB; Zambricki EA; Kambham N; Beilhack A; Loh J; Hou JZ; Negrin RS
    Blood; 2008 Jan; 111(1):453-62. PubMed ID: 17967941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel mTORC1-Dependent, Akt-Independent Pathway Differentiates the Gut Tropism of Regulatory and Conventional CD4 T Cells.
    Chen LC; Nicholson YT; Rosborough BR; Thomson AW; Raimondi G
    J Immunol; 2016 Aug; 197(4):1137-47. PubMed ID: 27402696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C-θ inhibits inducible regulatory T cell differentiation via an AKT-Foxo1/3a-dependent pathway.
    Ma J; Ding Y; Fang X; Wang R; Sun Z
    J Immunol; 2012 Jun; 188(11):5337-47. PubMed ID: 22539794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N,N-dimethylsphingosine attenuates myocardial ischemia-reperfusion injury by recruiting regulatory T cells through PI3K/Akt pathway in mice.
    Fang J; Hu F; Ke D; Yan Y; Liao Z; Yuan X; Wu L; Jiang Q; Chen L
    Basic Res Cardiol; 2016 May; 111(3):32. PubMed ID: 27048490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: PHLPP regulates the development, function, and molecular signaling pathways of regulatory T cells.
    Patterson SJ; Han JM; Garcia R; Assi K; Gao T; O'Neill A; Newton AC; Levings MK
    J Immunol; 2011 May; 186(10):5533-7. PubMed ID: 21498666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of E protein activity facilitates the quiescence exit of naïve CD4
    Yu S; Zhang J; Liu C; Sun X; Pang X; Li Y; Sun X; Jin R; Zhang Y
    Cell Immunol; 2020 May; 351():104065. PubMed ID: 32089259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch-1 Inhibition Promotes Immune Regulation in Transplantation Via Regulatory T Cell-Dependent Mechanisms.
    Magee CN; Murakami N; Borges TJ; Shimizu T; Safa K; Ohori S; Cai S; Uffing A; Azzi J; Elyaman W; Charbonnier LM; Liu K; Toprak D; Visner G; Chatila TA; Siebel CW; Najafian N; Riella LV
    Circulation; 2019 Sep; 140(10):846-863. PubMed ID: 31266349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications for immunotherapy of tumor-mediated T-cell apoptosis associated with loss of the tumor suppressor PTEN in glioblastoma.
    Waldron JS; Yang I; Han S; Tihan T; Sughrue ME; Mills SA; Pieper RO; Parsa AT
    J Clin Neurosci; 2010 Dec; 17(12):1543-7. PubMed ID: 20822910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T cells restrain CD4+ T cells from causing unregulated immune activation and hypersensitivity to lipopolysaccharide challenge.
    Okeke EB; Okwor I; Uzonna JE
    J Immunol; 2014 Jul; 193(2):655-62. PubMed ID: 24943218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI3K-Akt signaling controls PFKFB3 expression during human T-lymphocyte activation.
    Simon-Molas H; Arnedo-Pac C; Fontova P; Vidal-Alabró A; Castaño E; Rodríguez-García A; Navarro-Sabaté À; Lloberas N; Manzano A; Bartrons R
    Mol Cell Biochem; 2018 Nov; 448(1-2):187-197. PubMed ID: 29435871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+CD25+ regulatory T cells attenuate the phosphatidylinositol 3-kinase/Akt pathway in antigen-primed immature CD8+ CTLs during functional maturation.
    Kojima H; Kanno Y; Hase H; Kobata T
    J Immunol; 2005 May; 174(10):5959-67. PubMed ID: 15879088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontline: The p85alpha isoform of phosphoinositide 3-kinase is essential for a subset of B cell receptor-initiated signaling responses.
    Hess KL; Donahue AC; Ng KL; Moore TI; Oak J; Fruman DA
    Eur J Immunol; 2004 Nov; 34(11):2968-76. PubMed ID: 15384044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.